Antibody Drug Conjugates And Bioconjugates



Partnering / Pipeline

Catalent Biologics offers flexible options for our partners to employ SMARTag® in their bioconjugate and ADC programs, including broad research licenses, target-specific commercial licenses, co-development / product participation deals, and bundled deals including GPEx® cell line development, antibody manufacturing, and analytical services. To inquire about possible SMARTag collaboration opportunities, including partnerships around our proprietary preclinical CD22 and HER2 ADC programs, please click here.

SMARTag ADC Bioconjugate Pipeline